GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adherium Ltd (ASX:ADRDA) » Definitions » EV-to-EBIT

Adherium (ASX:ADRDA) EV-to-EBIT : -0.63 (As of May. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Adherium EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Adherium's Enterprise Value is A$5.85 Mil. Adherium's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-9.24 Mil. Therefore, Adherium's EV-to-EBIT for today is -0.63.

The historical rank and industry rank for Adherium's EV-to-EBIT or its related term are showing as below:

ASX:ADRDA' s EV-to-EBIT Range Over the Past 10 Years
Min: -1.67   Med: -0.19   Max: 0.82
Current: -0.63

During the past 7 years, the highest EV-to-EBIT of Adherium was 0.82. The lowest was -1.67. And the median was -0.19.

ASX:ADRDA's EV-to-EBIT is ranked worse than
100% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.17 vs ASX:ADRDA: -0.63

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Adherium's Enterprise Value for the quarter that ended in Dec. 2023 was A$15.55 Mil. Adherium's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-9.24 Mil. Adherium's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -59.42%.


Adherium EV-to-EBIT Historical Data

The historical data trend for Adherium's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adherium EV-to-EBIT Chart

Adherium Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBIT
Get a 7-Day Free Trial -0.35 -1.12 -1.64 -0.91 -0.35

Adherium Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.91 - -0.35 -

Competitive Comparison of Adherium's EV-to-EBIT

For the Medical Devices subindustry, Adherium's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adherium's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adherium's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Adherium's EV-to-EBIT falls into.



Adherium EV-to-EBIT Calculation

Adherium's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=5.847/-9.24
=-0.63

Adherium's current Enterprise Value is A$5.85 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adherium's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-9.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adherium  (ASX:ADRDA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Adherium's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-9.24/15.549444372
=-59.42 %

Adherium's Enterprise Value for the quarter that ended in Dec. 2023 was A$15.55 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adherium's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-9.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adherium EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Adherium's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Adherium (ASX:ADRDA) Business Description

Traded in Other Exchanges
N/A
Address
333 Collins Street, Level 14, Melbourne, VIC, AUS, 3000
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. Geographically, it derives a majority of its revenue from Europe and also has a presence in New Zealand and Australia; North America, and Asia.

Adherium (ASX:ADRDA) Headlines

No Headlines